COMPLETED

Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In the United States, carriers of hereditary genetic mutations have up to an 85% risk of developing breast cancer compared to 12% in the general population. Overall uptake of genetic services is generally low, particularly among high-risk African American (AA) women, who carry a disproportionate burden of breast cancer mortality. Further, although testing close relatives of individuals who test positive for a pathogenic variant might curtail breast cancer disparities attributable to hereditary risk, it is unclear how counseled or tested individuals influence their social and familial networks. Using a randomized control trial design, the objective of this research project is to test the effectiveness of a culturally targeted video, previously developed by our research team, on promoting genetic counseling attendance among AA women determined to be at high risk for breast cancer through cancer genetic risk assessment in a clinical setting. This study will also test how psychosocial factors (knowledge, intrinsic motivation, risk perception, and distress) impact the relationships between intervention exposures (video versus brochure) and compare the impact of intervention exposures on diffusion of knowledge about genetic counseling through social network analysis.

Official Title

Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer

Quick Facts

Study Start:2023-06-06
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04378751

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Are female
  2. 2. Identify as African American
  3. 3. Are age 25 or older
  4. 4. Speak and understand English
  5. 5. Completed a cancer genetic risk assessment (CGRA) as part of clinic intake
  6. 6. Are classified as high risk for developing breast cancer per CGRA
  7. 7. Have not previously received genetic counseling
  1. 1. Are not female
  2. 2. Do not identify as African American
  3. 3. Are age 24 or younger
  4. 4. Do not speak and understand English
  5. 5. Did not complete a cancer genetic risk assessment (CGRA) as part of clinic intake
  6. 6. Are not classified as high risk for developing breast cancer per CGRA
  7. 7. Have previously received genetic counseling

Contacts and Locations

Principal Investigator

Kent Hoskins, MD
PRINCIPAL_INVESTIGATOR
University of Illinois at Chicago

Study Locations (Sites)

UIC Cancer Center
Chicago, Illinois, 60612
United States
University of Illinois at Chicago Hospital and Ambulatory Clinics
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: University of Illinois at Chicago

  • Kent Hoskins, MD, PRINCIPAL_INVESTIGATOR, University of Illinois at Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-06
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2023-06-06
Study Completion Date2025-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • High Risk for Breast Cancer